Rate of non-oncology orphan medicine availability Europe 2025, by country

Percentage of non-oncology new orphan drugs approved by the EMA available to patients in Europe as of 2025, by country

Share of new non-oncology orphan medicines available in Europe in 2025, by country

Last update:

Jul 15, 2025

Author:

��ƽ�� Research Department

Region:

Europe

Survey time period:

From 01/01/2020 to 05/01/2025

This statistic displays the share of non-oncology orphan drugs approved by the European Medicines Agency (EMA) between 2020 and 2023 which were available to patients in selected European countries as of January 5, 2025. According to the data, 85 percent of approved non-oncology orphan medicines were available to patients in Germany, followed by 74 percent in Italy.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Percentage of non-oncology new orphan drugs approved by the EMA available to patients in Europe as of 2025, by country

Get in touch with us for additional information

��ƽ��